Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

In vivo evidence of glutamate toxicity in multiple sclerosis.

Azevedo CJ, Kornak J, Chu P, Sampat M, Okuda DT, Cree BA, Nelson SJ, Hauser SL, Pelletier D.

Ann Neurol. 2014 Aug;76(2):269-78. doi: 10.1002/ana.24202. Epub 2014 Jul 9.

2.

Magnetic resonance spectroscopy markers of disease progression in multiple sclerosis.

Llufriu S, Kornak J, Ratiney H, Oh J, Brenneman D, Cree BA, Sampat M, Hauser SL, Nelson SJ, Pelletier D.

JAMA Neurol. 2014 Jul 1;71(7):840-7. doi: 10.1001/jamaneurol.2014.895.

PMID:
24839987
3.

Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.

Tisell A, Leinhard OD, Warntjes JB, Aalto A, Smedby Ö, Landtblom AM, Lundberg P.

PLoS One. 2013 Apr 17;8(4):e61817. doi: 10.1371/journal.pone.0061817. Print 2013.

5.

Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis.

Staffen W, Zauner H, Mair A, Kutzelnigg A, Kapeller P, Stangl H, Raffer E, Niederhofer H, Ladurner G.

J Neuropsychiatry Clin Neurosci. 2005 Summer;17(3):357-63.

PMID:
16179658
6.

Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy.

Ruiz-Peña JL, Piñero P, Sellers G, Argente J, Casado A, Foronda J, Uclés A, Izquierdo G.

BMC Neurol. 2004 Jun 10;4:8.

7.

(1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.

Sijens PE, Mostert JP, Oudkerk M, De Keyser J.

Eur Radiol. 2006 Feb;16(2):489-95. Epub 2005 Jul 19.

PMID:
16028056
8.

MR spectroscopy (MRS) and magnetisation transfer imaging (MTI), lesion load and clinical scores in early relapsing remitting multiple sclerosis: a combined cross-sectional and longitudinal study.

Bellmann-Strobl J, Stiepani H, Wuerfel J, Bohner G, Paul F, Warmuth C, Aktas O, Wandinger KP, Zipp F, Klingebiel R.

Eur Radiol. 2009 Aug;19(8):2066-74. doi: 10.1007/s00330-009-1364-z. Epub 2009 Mar 24.

PMID:
19308417
9.

Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.

Sastre-Garriga J, Ingle GT, Chard DT, Ramió-Torrentà L, McLean MA, Miller DH, Thompson AJ.

Arch Neurol. 2005 Apr;62(4):569-73.

PMID:
15824254
10.

Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosis.

Cucurella MG, Rovira A, Río J, Pedraza S, Tintoré MM, Montalbán X, Alonso J.

NMR Biomed. 2000 Apr;13(2):57-63.

PMID:
10797633
11.

Hypothalamic damage in multiple sclerosis correlates with disease activity, disability, depression, and fatigue.

Kantorová E, Poláček H, Bittšanský M, Baranovičová E, Hnilicová P, Čierny D, Sivák Š, Nosáľ V, Zeleňák K, Kurča E.

Neurol Res. 2017 Apr;39(4):323-330. doi: 10.1080/01616412.2016.1275460. Epub 2017 Feb 13.

PMID:
28191860
12.

Performance on Paced Auditory Serial Addition Test and cerebral blood flow in multiple sclerosis.

D'haeseleer M, Steen C, Hoogduin JM, van Osch MJ, Fierens Y, Cambron M, Koch MW, De Keyser J.

Acta Neurol Scand. 2013 Nov;128(5):e26-9. doi: 10.1111/ane.12129. Epub 2013 Apr 1.

PMID:
23550954
13.

Imaging axonal damage of normal-appearing white matter in multiple sclerosis.

Fu L, Matthews PM, De Stefano N, Worsley KJ, Narayanan S, Francis GS, Antel JP, Wolfson C, Arnold DL.

Brain. 1998 Jan;121 ( Pt 1):103-13.

PMID:
9549491
14.

Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.

De Stefano N, Narayanan S, Francis GS, Arnaoutelis R, Tartaglia MC, Antel JP, Matthews PM, Arnold DL.

Arch Neurol. 2001 Jan;58(1):65-70.

PMID:
11176938
15.

Metabolic changes in normal appearing white matter in multiple sclerosis patients using multivoxel magnetic resonance spectroscopy imaging.

Sun J, Song H, Yang Y, Zhang K, Gao X, Li X, Ni L, Lin P, Niu C.

Medicine (Baltimore). 2017 Apr;96(14):e6534. doi: 10.1097/MD.0000000000006534.

16.

The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.

Pardini M, Botzkowski D, Müller S, Vehoff J, Kuhle J, Ruberte E, Würfel J, Gass A, Valmaggia C, Tettenborn B, Putzki N, Yaldizli Ö.

Eur J Neurol. 2016 Dec;23(12):1769-1774. doi: 10.1111/ene.13116. Epub 2016 Sep 3.

PMID:
27591406
17.
18.

MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter.

Vrenken H, Barkhof F, Uitdehaag BM, Castelijns JA, Polman CH, Pouwels PJ.

Magn Reson Med. 2005 Feb;53(2):256-66.

19.
20.

Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient.

De Stefano N, Matthews PM, Narayanan S, Francis GS, Antel JP, Arnold DL.

Neurology. 1997 Oct;49(4):1138-41.

PMID:
9339704

Supplemental Content

Support Center